CT-P17

adalimumab biosimilar · Celltrion

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CT-P17, covering 2020-12-07 to 2024-08-21. Get the full timeline:

Most recent: Clinical Trial Update: To Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

See pricing